IL37 and breast cancer: Importantly, the suppression of the development of breast cancer is abrogated in recipients with T cell deficient BALB/c nude mice, in the presence of exogenous IL-37 administration, suggesting the important anti-tumour role of IL-37β is T cell mediated (61).